Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis.

International Journal of Molecular Sciences
Paul R J AmesFabrizio Gentile

Abstract

The relationship between antiphospholipid antibodies (aPL) and autoimmune haemolytic anaemia (AIHA) has never been systematically addressed. The aim of this study is to assess the link between aPL and AIHA in adult systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). This study performed an EMBASE/PubMed search from inception to June 2019 and meta-analysis using Peto's odds ratios. The pooled prevalence (PP) of IgG/IgM anticardiolipin (aCL) and lupus anticoagulant (LA) was greater in AIHA +ve than AIHA -ve patients (34.7% vs. 27.6%, p = 0.03; 33.3% vs. 21.8%, p < 0.0001; 20.9% vs. 8.3%, p = 0.01). The PP of AIHA was greater in: (1) IgG and IgM aCL +ve than -ve patients (21.8% vs. 11.1%, p = 0.001 and 18.7% vs. 6.3%, p < 0.0001), (2) in SLE related APS than in primary APS patients (22.8% vs. 3.9% p < 0.0001), (3) in APS +ve than APS -ve SLE patients (23.2% vs. 8.4%, p = 0.01), and (4) in thrombotic APS than non-thrombotic APS/SLE patients (26.8% vs. 10%, p = 0.03). The PP of IgG/IgM aCL and LA was greater in DAT +ve than DAT -ve patients (42.4% vs. 12.8%, p < 0.0001; 26.2% vs. 12.8%, p = 0.03 and 29.2% vs. 15.7%, p = 0.004 respectively). It was found that AIHA prevalence is maximal in SLE with aPL/APS, low-mod...Continue Reading

References

Nov 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E FarrugiaK E Holley
Jan 1, 1989·European Journal of Haematology·A KornbergS Kaufman
Jan 1, 1987·The American Journal of the Medical Sciences·M AverbuchY Levo
Jan 1, 1987·Scandinavian Journal of Rheumatology·R H DerksenL Kater
Dec 1, 1995·The American Journal of Medicine·M Abu-ShakraV Farewell
Feb 1, 1994·Clinical and Experimental Immunology·J ArvieuxM G Colomb
Jan 1, 1995·Nephron·M PerdigueroF Rivera
Jan 6, 2000·Seminars in Arthritis and Rheumatism·F J Muñoz-RodriguezM Ingelmo
Feb 29, 2000·Arthritis and Rheumatism·M D LockshinS Schwartzman
Mar 4, 2000·Annals of the Rheumatic Diseases·M VoulgarelisH M Moutsopoulos
May 17, 2000·Journal of Clinical Epidemiology·J L Tang, J L Liu
Aug 5, 2000·QJM : Monthly Journal of the Association of Physicians·M G TektonidouH M Moutsopoulos
Mar 23, 2002·Journal of Autoimmunity·Javier CabiedesDonato Alarcón-Segovia
May 25, 2006·Medicine·Nuntana KasitanonMichelle Petri
Sep 16, 2006·BMJ : British Medical Journal·Joseph LauIngram Olkin
Sep 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Konstantinos RitisJohn D Lambris
Nov 15, 2006·The Journal of Experimental Medicine·Michael E GreenbergStanley L Hazen
May 18, 2010·Clinical Rheumatology·Diogo Souza Domiciano, Samuel Katsuyuki Shinjo

❮ Previous
Next ❯

Citations

Mar 9, 2021·Expert Review of Clinical Immunology·Georges El HasbaniImad Uthman
May 1, 2021·Journal of Clinical Medicine·Marco CapecchiIda Martinelli
Aug 4, 2021·The American Journal of Medicine·Meng Jia ChenDesmond B Teo

❮ Previous
Next ❯

Software Mentioned

EndNote
Comprehensive Meta - Analysis (

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.